Provectus Biopharmaceuticals Inc

OTC: PVCT    
Share price (4/26/24): $0.20    
Market cap (4/26/24): $83.3 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.5
from 10-K 3 pages Description of Securities Registered Under Section 12 of the Exchange Act
12/34/56
EX-4.5
from 10-K 3 pages Description of Securities Registered Under Section 12 of the Exchange Act
12/34/56
EX-4.1
from 8-K 10 pages Unsecured Convertible Promissory Note
12/34/56
EX-4.4
from 10-K 4 pages Description of Securities Registered Under Section 12 of the Exchange Act
12/34/56
EX-4.1
from 8-K 11 pages Unsecured Convertible Promissory Note
12/34/56
EX-4.4
from 10-K 4 pages Description of Securities Registered Under Section 12 of the Exchange Act
12/34/56
EX-4.10
from 10-K 5 pages Description of Securities Registered Under Section 12 of the Exchange Act
12/34/56
EX-4.1
from 8-K 15 pages Prh 2 Secured Convertible Promissory Note
12/34/56
EX-4.4
from S-1/A 10 pages Provectus Biopharmaceuticals, Inc. Warrant to Purchase Common Stock
12/34/56
EX-4.3
from S-1/A 14 pages Warrant Agency Agreement
12/34/56
EX-4.2
from S-1/A 4 pages Form of Non-Transferable Subscription Rights Certificate
12/34/56
EX-4.2
from S-1/A 4 pages Form of Non-Transferable Subscription Rights Certificate
12/34/56
EX-4.2
from S-1/A 4 pages Form of Non-Transferable Subscription Rights Certificate
12/34/56
EX-4.2
from S-1 4 pages Form of Non-Transferable Subscription Rights Certificate
12/34/56
EX-4.1
from 8-K 14 pages Form of Warrant Provectus Biopharmaceuticals, Inc. Series a Warrant to Purchase Common Stock
12/34/56
EX-4.6
from S-4 12 pages Exchange and Escrow Agent Agreement
12/34/56
EX-4.4
from S-4 4 pages Second Amendment to Warrant Agency Agreement
12/34/56
EX-4.5
from S-4 12 pages Exchange and Escrow Agent Agreement
12/34/56
EX-4.3
from S-4 3 pages First Amendment to Warrant Agency Agreement
12/34/56
EX-4.1
from S-4 2 pages Indenture or similar
12/34/56